Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Sensei Biotherapeutics Analyst Ratings and Price Targets | NASDAQ:SNSE | Benzinga
Sensei Biotherapeutics Inc has a consensus price target of $4.4 based on the ratings of 5 analysts. The high is $5 issued by HC Wainwright & Co. on June 2, 2025. The low is $4 issued by Oppenheimer on March 28, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Oppenheimer, and HC Wainwright & Co. on June 2, 2025, March 28, 2025, and March 28, 2025, respectively. With an average price target of $4.33 between HC Wainwright & Co., Oppenheimer, and HC Wainwright & Co., there's an implied 1083.97% upside for Sensei Biotherapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Oppenheimer
HC Wainwright & Co.
Citigroup
Stephens & Co.
1calculated from analyst ratings
Analyst Ratings for Sensei Biotherapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/02/2025 | Buy Now | 1266.12% | HC Wainwright & Co. | Matthew Kelsey21% | → $5 | Assumes | → Buy | Get Alert |
| 03/28/2025 | Buy Now | 992.9% | Oppenheimer | Francois Brisebois40% | $3.5 → $4 | Maintains | Outperform | Get Alert |
| 03/28/2025 | Buy Now | 992.9% | HC Wainwright & Co. | Edward White47% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 01/10/2025 | Buy Now | 992.9% | HC Wainwright & Co. | Edward White47% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 01/08/2025 | Buy Now | 992.9% | HC Wainwright & Co. | Edward White47% | $4 → $4 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 992.9% | HC Wainwright & Co. | Edward White47% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 992.9% | Citigroup | Samantha Semenkow34% | → $4 | Reinstates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 992.9% | HC Wainwright & Co. | Edward White47% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | 1266.12% | Stephens & Co. | Sudan Loganathan41% | $5 → $5 | Reiterates | Overweight → Overweight | Get Alert |
| 05/14/2024 | Buy Now | 1266.12% | Stephens & Co. | Sudan Loganathan41% | → $5 | Initiates | → Overweight | Get Alert |
| 12/04/2023 | Buy Now | 992.9% | HC Wainwright & Co. | Edward White47% | → $4 | Initiates | → Buy | Get Alert |
| 12/13/2022 | Buy Now | 1539.34% | Citigroup | Samantha Semenkow34% | → $6 | Initiates | → Buy | Get Alert |
| 10/03/2022 | Buy Now | 1266.12% | Oppenheimer | Francois Brisebois40% | → $5 | Upgrade | Perform → Outperform | Get Alert |
FAQ
What is the target price for Sensei Biotherapeutics (SNSE) stock?
The latest price target for Sensei Biotherapeutics (NASDAQ:SNSE) was reported by HC Wainwright & Co. on June 2, 2025. The analyst firm set a price target for $5.00 expecting SNSE to rise to within 12 months (a possible 1266.12% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sensei Biotherapeutics (SNSE)?
The latest analyst rating for Sensei Biotherapeutics (NASDAQ:SNSE) was provided by HC Wainwright & Co., and Sensei Biotherapeutics their buy rating.
When was the last upgrade for Sensei Biotherapeutics (SNSE)?
The last upgrade for Sensei Biotherapeutics Inc happened on October 3, 2022 when Oppenheimer raised their price target to $5. Oppenheimer previously had a perform for Sensei Biotherapeutics Inc.
When was the last downgrade for Sensei Biotherapeutics (SNSE)?
There is no last downgrade for Sensei Biotherapeutics.
When is the next analyst rating going to be posted or updated for Sensei Biotherapeutics (SNSE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensei Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensei Biotherapeutics was filed on June 2, 2025 so you should expect the next rating to be made available sometime around June 2, 2026.
Is the Analyst Rating Sensei Biotherapeutics (SNSE) correct?
While ratings are subjective and will change, the latest Sensei Biotherapeutics (SNSE) rating was a with a price target of $0.00 to $5.00. The current price Sensei Biotherapeutics (SNSE) is trading at is $0.37, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
